3.5.0.2 html 127 260 1 true 34 0 false 4 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.rxipharma.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 103 - Statement - Condensed Balance Sheets Sheet http://www.rxipharma.com/taxonomy/role/StatementOfFinancialPositionClassified Condensed Balance Sheets Statements 2 false false R3.htm 104 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.rxipharma.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 105 - Statement - Condensed Statements of Operations Sheet http://www.rxipharma.com/taxonomy/role/StatementOfIncomeAlternative Condensed Statements of Operations Statements 4 false false R5.htm 106 - Statement - Condensed Statements of Operations (Parenthetical) Sheet http://www.rxipharma.com/taxonomy/role/StatementOfIncomeAlternativeParenthetical Condensed Statements of Operations (Parenthetical) Statements 5 false false R6.htm 107 - Statement - Condensed Statements of Cash Flows Sheet http://www.rxipharma.com/taxonomy/role/StatementOfCashFlowsIndirect Condensed Statements of Cash Flows Statements 6 false false R7.htm 108 - Statement - Statements of Convertible Preferred Stock and Stockholders Equity Sheet http://www.rxipharma.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Statements of Convertible Preferred Stock and Stockholders Equity Statements 7 false false R8.htm 109 - Statement - Statements of Convertible Preferred Stock and Stockholders Equity (Parenthetical) Sheet http://www.rxipharma.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical Statements of Convertible Preferred Stock and Stockholders Equity (Parenthetical) Statements 8 false false R9.htm 110 - Disclosure - Nature of Operations Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations Nature of Operations Notes 9 false false R10.htm 111 - Disclosure - Liquidity and Going Concern Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsSubstantialDoubtAboutGoingConcernTextBlock Liquidity and Going Concern Notes 10 false false R11.htm 112 - Disclosure - Significant Accounting Policies Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Significant Accounting Policies Notes 11 false false R12.htm 113 - Disclosure - Recent Accounting Pronouncements Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock Recent Accounting Pronouncements Notes 12 false false R13.htm 114 - Disclosure - Other Assets Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsOtherAssetsDisclosureTextBlock Other Assets Notes 13 false false R14.htm 115 - Disclosure - Fair Value Measurements Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value Measurements Notes 14 false false R15.htm 116 - Disclosure - Stockholders' Equity Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Stockholders' Equity Notes 15 false false R16.htm 117 - Disclosure - Stock-based Compensation Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock-based Compensation Notes 16 false false R17.htm 118 - Disclosure - Net Loss per Share Attributable to Common Stockholders Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Net Loss per Share Attributable to Common Stockholders Notes 17 false false R18.htm 119 - Disclosure - Subsequent Events Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock Subsequent Events Notes 18 false false R19.htm 120 - Disclosure - Accrued Expenses Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock Accrued Expenses Notes 19 false false R20.htm 121 - Disclosure - Commitments and Contingencies Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies Notes 20 false false R21.htm 122 - Disclosure - Convertible Preferred Stock Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsTemporaryEquityTextBlock Convertible Preferred Stock Notes 21 false false R22.htm 123 - Disclosure - Income Taxes Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes Notes 22 false false R23.htm 124 - Disclosure - License Agreements Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsResearchDevelopmentAndComputerSoftwareDisclosureTextBlock License Agreements Notes 23 false false R24.htm 125 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Significant Accounting Policies (Policies) Policies http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock 24 false false R25.htm 126 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value Measurements (Tables) Tables http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock 25 false false R26.htm 127 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables Stockholders' Equity (Tables) Tables http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock 26 false false R27.htm 128 - Disclosure - Stock-based Compensation (Tables) Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock-based Compensation (Tables) Tables http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock 27 false false R28.htm 129 - Disclosure - Net Loss per Share Attributable to Common Stockholders (Tables) Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Net Loss per Share Attributable to Common Stockholders (Tables) Tables http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock 28 false false R29.htm 130 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockTables Significant Accounting Policies (Tables) Tables http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock 29 false false R30.htm 131 - Disclosure - Accrued Expenses (Tables) Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables Accrued Expenses (Tables) Tables http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock 30 false false R31.htm 132 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables Commitments and Contingencies (Tables) Tables http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock 31 false false R32.htm 133 - Disclosure - Income Taxes (Tables) Sheet http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables Income Taxes (Tables) Tables http://www.rxipharma.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock 32 false false R33.htm 134 - Disclosure - Nature of Operations - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureNatureOfOperationsAdditionalInformation Nature of Operations - Additional Information (Detail) Details 33 false false R34.htm 135 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformation Significant Accounting Policies - Additional Information (Detail) Details 34 false false R35.htm 136 - Disclosure - Other Assets - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureOtherAssetsAdditionalInformation Other Assets - Additional Information (Detail) Details 35 false false R36.htm 137 - Disclosure - Fair Value Measurements - Fair Value Measurements (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureFairValueMeasurementsFairValueMeasurements Fair Value Measurements - Fair Value Measurements (Detail) Details 36 false false R37.htm 138 - Disclosure - Fair Value Measurements - Schedule of Additional Information about Assets Measured at Fair Value on a Recurring Basis (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAdditionalInformationAboutAssetsMeasuredAtFairValueOnARecurringBasis Fair Value Measurements - Schedule of Additional Information about Assets Measured at Fair Value on a Recurring Basis (Detail) Details 37 false false R38.htm 139 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation Stockholders' Equity - Additional Information (Detail) Details 38 false false R39.htm 140 - Disclosure - Stockholders' Equity - Summary of Warrants Outstanding (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureStockholdersEquitySummaryOfWarrantsOutstanding Stockholders' Equity - Summary of Warrants Outstanding (Detail) Details 39 false false R40.htm 141 - Disclosure - Stock-based Compensation - Schedule of Assumptions Used to Determine Fair Value of Option Grants (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedToDetermineFairValueOfOptionGrants Stock-based Compensation - Schedule of Assumptions Used to Determine Fair Value of Option Grants (Detail) Details 40 false false R41.htm 142 - Disclosure - Stock-based Compensation - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformation Stock-based Compensation - Additional Information (Detail) Details 41 false false R42.htm 143 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivity Stock-based Compensation - Summary of Stock Option Activity (Detail) Details 42 false false R43.htm 144 - Disclosure - Net Loss per Share Attributable to Common Stockholders - Common Shares Excluded from the Calculation of Net Loss per Common Share Attributable to Common Stockholders (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureNetLossPerShareAttributableToCommonStockholdersCommonSharesExcludedFromTheCalculationOfNetLossPerCommonShareAttributableToCommonStockholders Net Loss per Share Attributable to Common Stockholders - Common Shares Excluded from the Calculation of Net Loss per Common Share Attributable to Common Stockholders (Detail) Details 43 false false R44.htm 145 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation Subsequent Events - Additional Information (Detail) Details 44 false false R45.htm 146 - Disclosure - Summary of Significant Accounting Policies - Summary of Depreciation Over Assets' Estimated Useful Lives (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfDepreciationOverAssetsEstimatedUsefulLives Summary of Significant Accounting Policies - Summary of Depreciation Over Assets' Estimated Useful Lives (Detail) Details 45 false false R46.htm 147 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpenses Accrued Expenses - Schedule of Accrued Expenses (Detail) Details 46 false false R47.htm 148 - Disclosure - Commitments and Contingencies - Future Cash Payments Under Contractual License Obligations (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureCommitmentsAndContingenciesFutureCashPaymentsUnderContractualLicenseObligations Commitments and Contingencies - Future Cash Payments Under Contractual License Obligations (Detail) Details 47 false false R48.htm 149 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation Commitments and Contingencies - Additional Information (Detail) Details 48 false false R49.htm 150 - Disclosure - Commitments and Contingencies - Future Minimum Payments Under Operating Leases (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureCommitmentsAndContingenciesFutureMinimumPaymentsUnderOperatingLeases Commitments and Contingencies - Future Minimum Payments Under Operating Leases (Detail) Details 49 false false R50.htm 151 - Disclosure - Convertible Preferred Stock - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformation Convertible Preferred Stock - Additional Information (Detail) Details 50 false false R51.htm 152 - Disclosure - Income Taxes - Components of Federal and State Income Tax Expense (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureIncomeTaxesComponentsOfFederalAndStateIncomeTaxExpense Income Taxes - Components of Federal and State Income Tax Expense (Detail) Details 51 false false R52.htm 153 - Disclosure - Income Taxes - Effect Income Tax Rate Reconciliation (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureIncomeTaxesEffectIncomeTaxRateReconciliation Income Taxes - Effect Income Tax Rate Reconciliation (Detail) Details 52 false false R53.htm 154 - Disclosure - Income Taxes - Components of Net Deferred Tax Assets (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureIncomeTaxesComponentsOfNetDeferredTaxAssets Income Taxes - Components of Net Deferred Tax Assets (Detail) Details 53 false false R54.htm 155 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation Income Taxes - Additional Information (Detail) Details 54 false false R55.htm 156 - Disclosure - License Agreements - Additional Information (Detail) Sheet http://www.rxipharma.com/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformation License Agreements - Additional Information (Detail) Details 55 false false All Reports Book All Reports rxii-20160630.xml rxii-20160630.xsd rxii-20160630_cal.xml rxii-20160630_def.xml rxii-20160630_lab.xml rxii-20160630_pre.xml true true